Shamik Sen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shamik Sen has a total of 247 co-authors. Here are the top co-authors by number of shared publications:
- Dennis E. Discher
Molecular and Cell Biophysics Lab, University of Pennsylvania, Philadelphia, PA 19104, USA
14 shared publications Alakesh Das
IIT Bombay 1 Dept. of Biosciences & Bioengineering Mumbai 400076
10 shared publicationsSarbajeet Dutta
Department of Biosciences & Bioengineering IIT Bombay India
10 shared publicationsAmlan Barai
Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Mumbai 400076, India
9 shared publications- Sanjay Kumar
UC Berkeley Chemical and Biomolecular Engineering
8 shared publications - Amlan Barai
Dept. of Biosciences & Bioengineering, IIT Bombay, Mumbai, India
7 shared publications
Latest Publications
- Open Access
Glycocalyx-Directed Enzymatic Hydrogels Unlocks Fibroblast Regeneration to Promote Diabetic Wound Healing
Chronic diabetic wounds remain a major clinical challenge because current therapies address infection or supplement growth factors without correcting the cellular dysfunction that prevents regeneration. We identify pathological glycocalyx thickening in diabetic dermal fibroblasts (DDFs) as a driver of elevated caspase 3, 8, and 9 expression and heightened apoptosis — deficits that stall wound repair. Cleavage of sialic acid residues by neuraminidase (NMase) reverses this dysfunction, restoring fibroblast migration, proliferation, and contractility. We engineer a photo-crosslinked hybrid hydrogel combining methacrylated gelatin (GelMA) with high-molecular-weight methacrylated chitosan (HMW ChMA). ChMA increases storage modulus 8–12-fold, reduces pore size, and confers antibacterial activity against gram-positive and gram-negative bacteria, addressing infection susceptibility. The fortified HMW hybrid (HMWH) network enables sustained, localized NMase delivery that outperforms GelMA alone in resisting degradation and controlling release kinetics. NMase-loaded HMWH (N-HMWH) gels enhance DDF proliferation and migration in vitro, correlating with reduced focal adhesion size and increased turnover. In a diabetic rat model, N-HMWH patches achieve superior wound closure, outperforming EGF therapy, with robust epidermal regeneration, neovascularization, and collagen deposition. This work establishes glycocalyx-targeting hydrogels as a new class of wound therapeutics addressing the root cause of diabetic fibroblast failure, not just compensating with growth factors.
Open AccessGlycocalyx-Directed Enzymatic Hydrogels Unlocks Fibroblast Regeneration to Promote Diabetic Wound Healing
Chronic diabetic wounds remain a major clinical challenge because current therapies address infection or supplement growth factors without correcting the cellular dysfunction that prevents regeneration. We identify pathological glycocalyx thickening in diabetic dermal fibroblasts (DDFs) as a driver of elevated caspase 3, 8, and 9 expression and heightened apoptosis — deficits that stall wound repair. Cleavage of sialic acid residues by neuraminidase (NMase) reverses this dysfunction, restoring fibroblast migration, proliferation, and contractility. We engineer a photo-crosslinked hybrid hydrogel combining methacrylated gelatin (GelMA) with high-molecular-weight methacrylated chitosan (HMW ChMA). ChMA increases storage modulus 8–12-fold, reduces pore size, and confers antibacterial activity against gram-positive and gram-negative bacteria, addressing infection susceptibility. The fortified HMW hybrid (HMWH) network enables sustained, localized NMase delivery that outperforms GelMA alone in resisting degradation and controlling release kinetics. NMase-loaded HMWH (N-HMWH) gels enhance DDF proliferation and migration in vitro, correlating with reduced focal adhesion size and increased turnover. In a diabetic rat model, N-HMWH patches achieve superior wound closure, outperforming EGF therapy, with robust epidermal regeneration, neovascularization, and collagen deposition. This work establishes glycocalyx-targeting hydrogels as a new class of wound therapeutics addressing the root cause of diabetic fibroblast failure, not just compensating with growth factors.
- 25 June 2026
- Published by Wiley in The FEBS Journal
MMP9 drives cancer invasion by mediating integrin membrane trafficking and stabilization
Matrix stiffening promotes cancer progression by elevating matrix metalloprotease (MMP) activity, thereby enabling extracellular matrix degradation and migration. Yet, the nonproteolytic roles of MMPs in invasion remain less defined. Here, we dissect the proteolytic and nonproteolytic functions of MMP9, a metalloprotease whose expression and secretion increase sharply in highly invasive cancer cells in response to stiffness. We find that MMP9 supports cell spreading and 2D migration through a nonproteolytic mechanism that stabilizes focal adhesions, whereas its proteolytic activity is specifically required for 3D invasion. We further identify two distinct integrin β1 (ITGβ1) binding sites that coordinate these functions: The hemopexin domain drives copackaging and transport of the ITGβ1‐MMP9 complex to the cell periphery, while the RGD motif stabilizes ITGβ1 at the membrane before matrix degradation. These findings reveal a spatiotemporal mechanism by which MMP9 integrates adhesion dynamics with matrix remodeling to optimize invasive behavior.
- 25 June 2026
- Published by Wiley in The FEBS Journal
MMP9 drives cancer invasion by mediating integrin membrane trafficking and stabilization
Matrix stiffening promotes cancer progression by elevating matrix metalloprotease (MMP) activity, thereby enabling extracellular matrix degradation and migration. Yet, the nonproteolytic roles of MMPs in invasion remain less defined. Here, we dissect the proteolytic and nonproteolytic functions of MMP9, a metalloprotease whose expression and secretion increase sharply in highly invasive cancer cells in response to stiffness. We find that MMP9 supports cell spreading and 2D migration through a nonproteolytic mechanism that stabilizes focal adhesions, whereas its proteolytic activity is specifically required for 3D invasion. We further identify two distinct integrin β1 (ITGβ1) binding sites that coordinate these functions: The hemopexin domain drives copackaging and transport of the ITGβ1‐MMP9 complex to the cell periphery, while the RGD motif stabilizes ITGβ1 at the membrane before matrix degradation. These findings reveal a spatiotemporal mechanism by which MMP9 integrates adhesion dynamics with matrix remodeling to optimize invasive behavior.
- 15 February 2026
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 139 (4)
Glucose deprivation induces AMPK-dependent α-actinin-4 expression to sustain energy efficient non-proteolytic migration
Crosstalk between tumor microenvironmental factors, such as extracellular matrix (ECM) stiffness and metabolic pathways, regulate cell invasive phenotype in cancer cells. ECM stiffening leads to the collapse of blood vessels leading to oxygen deprivation and nutrient stress. The individual and combined effect of these two factors on the mode of invasion of cancer cells remains poorly understood. Here, we show that in breast cancer cells, glucose deprivation induces a switch from an energy-demanding proteolytic mode of migration to an energy efficient non-proteolytic mode of migration. Energy demands met by OXPHOS and nuclear softening sustain this mode of migration. We further show that the energy sensor AMPK mediates this switch through transcriptional activation of the mechanoresponsive actin crosslinking protein α-actinin-4. Collectively, our results demonstrate how AMPK fine-tunes mode of invasion under nutrient constraints by transcriptional activation of α-actinin-4.
- 15 February 2026
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 139 (4)
Glucose deprivation induces AMPK-dependent α-actinin-4 expression to sustain energy efficient non-proteolytic migration
Crosstalk between tumor microenvironmental factors, such as extracellular matrix (ECM) stiffness and metabolic pathways, regulate cell invasive phenotype in cancer cells. ECM stiffening leads to the collapse of blood vessels leading to oxygen deprivation and nutrient stress. The individual and combined effect of these two factors on the mode of invasion of cancer cells remains poorly understood. Here, we show that in breast cancer cells, glucose deprivation induces a switch from an energy-demanding proteolytic mode of migration to an energy efficient non-proteolytic mode of migration. Energy demands met by OXPHOS and nuclear softening sustain this mode of migration. We further show that the energy sensor AMPK mediates this switch through transcriptional activation of the mechanoresponsive actin crosslinking protein α-actinin-4. Collectively, our results demonstrate how AMPK fine-tunes mode of invasion under nutrient constraints by transcriptional activation of α-actinin-4.
- Open Access
- 29 October 2025
- Published by Springer Nature in npj Systems Biology and Applications
- Vol. 11 (1) , 1-15
MMP9 shapes cell mechanics to enable collective invasion in cancer
Cooperation among phenotypically distinct sub-populations within a tumor plays a key role in cancer progression. In this study, we investigated how proteolytic heterogeneity supports collective cancer invasion. In invasive MDA-MB-231 breast cancer cells which exhibit considerable variability in MMP9 expression, we show that MMP9 knockdown cells are notably smaller and softer than control cells. A computational model revealed that the invasiveness of mixed clusters containing both proteolytic and non-proteolytic cells depends on cell-cell adhesion, with non-proteolytic cell invasion requiring close proximity to proteolytic neighbors. When we assigned non-proteolytic cells the same size and stiffness as proteolytic ones, the overall invasiveness declined–highlighting that small size and deformability of non-proteolytic cells are essential for sustained collective invasion. We validated these predictions experimentally using spheroid invasion assays showing that mixed spheroids of control and MMP9 knockdown cells are the most invasive. Together, our findings demonstrate that interplay between MMP9 expression and biophysical properties enables collective invasion through enrichment of and matrix degradation by high MMP9 expressing cells at the invasive front, and squeezing of low MMP9 expressing cells through the remodeled matrix.
- 29 October 2025
- Published by Springer Nature in npj Systems Biology and Applications
- Vol. 11 (1) , 1-15
Open AccessMMP9 shapes cell mechanics to enable collective invasion in cancer
Cooperation among phenotypically distinct sub-populations within a tumor plays a key role in cancer progression. In this study, we investigated how proteolytic heterogeneity supports collective cancer invasion. In invasive MDA-MB-231 breast cancer cells which exhibit considerable variability in MMP9 expression, we show that MMP9 knockdown cells are notably smaller and softer than control cells. A computational model revealed that the invasiveness of mixed clusters containing both proteolytic and non-proteolytic cells depends on cell-cell adhesion, with non-proteolytic cell invasion requiring close proximity to proteolytic neighbors. When we assigned non-proteolytic cells the same size and stiffness as proteolytic ones, the overall invasiveness declined–highlighting that small size and deformability of non-proteolytic cells are essential for sustained collective invasion. We validated these predictions experimentally using spheroid invasion assays showing that mixed spheroids of control and MMP9 knockdown cells are the most invasive. Together, our findings demonstrate that interplay between MMP9 expression and biophysical properties enables collective invasion through enrichment of and matrix degradation by high MMP9 expressing cells at the invasive front, and squeezing of low MMP9 expressing cells through the remodeled matrix.
- Open Access
- 5 September 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (17)
Nuclear compression-mediated DNA damage drives ATR-dependent Lamin expression and mouse ESC differentiation
Embryonic stem cells (ESCs), which are susceptible to DNA damage, depend on a robust and highly efficient DNA damage response (DDR) mechanism for their survival. However, the implications of physical force-mediated DNA damage on ESC fate remain unclear. We show that stiffness-dependent spreading of mouse ESCs (mESCs) induces DNA damage through nuclear compression, with DNA damage causing differentiation through Lamin A/C. Interestingly, differentiation is associated with DNA damage and activation of the DDR factors such as ATR and CHK1. While ATR is typically known to play roles in DDR pathway, its role during stiffness-mediated nuclear compression and mESC differentiation is unknown. While our results show activation of CHK1 pathway and nuclear enrichment of activated ATR on stiff substrates, inhibiting ATR and CHK1 both result in reduction of Lamin A/C expression by different mechanisms. Overall, we demonstrate that mESC differentiation is driven by nuclear compression-mediated DNA damage and involves ATR-dependent modulation of Lamin A/C.
- 5 September 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (17)
Open AccessNuclear compression-mediated DNA damage drives ATR-dependent Lamin expression and mouse ESC differentiation
Embryonic stem cells (ESCs), which are susceptible to DNA damage, depend on a robust and highly efficient DNA damage response (DDR) mechanism for their survival. However, the implications of physical force-mediated DNA damage on ESC fate remain unclear. We show that stiffness-dependent spreading of mouse ESCs (mESCs) induces DNA damage through nuclear compression, with DNA damage causing differentiation through Lamin A/C. Interestingly, differentiation is associated with DNA damage and activation of the DDR factors such as ATR and CHK1. While ATR is typically known to play roles in DDR pathway, its role during stiffness-mediated nuclear compression and mESC differentiation is unknown. While our results show activation of CHK1 pathway and nuclear enrichment of activated ATR on stiff substrates, inhibiting ATR and CHK1 both result in reduction of Lamin A/C expression by different mechanisms. Overall, we demonstrate that mESC differentiation is driven by nuclear compression-mediated DNA damage and involves ATR-dependent modulation of Lamin A/C.
- 29 April 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (19) , 15985-16006
Faster Amylin Aggregation on Fibrillar Collagen I Hastens Diabetic Progression through β-Cell Death and Loss of Function
Amyloid deposition of the neuroendocrine peptide amylin in islet tissues is a hallmark of type 2 diabetes (T2DM), leading to β-cell toxicity through nutrient deprivation, membrane rupture, and apoptosis. Though accumulation of toxic amylin aggregates in islet matrices is well documented, the role of the islet extracellular matrix in mediating amylin aggregation and its pathological consequences remains elusive. Here, we address this question by probing amylin interaction with collagen I (Col)─whose expression in the islet tissue increases during diabetes progression. By combining multiple biophysical techniques, we show that hydrophobic, hydrophilic, and cation-π interactions regulate amylin binding to Col, with fibrillar Col driving faster amylin aggregation. Amylin-entangled Col matrices containing high amounts of amylin induce death and loss of function in INS1E β-cells. Together, our results illustrate how amylin incorporation in islet matrices through amylin-Col interactions drives T2DM progression by impacting β-cell viability and insulin secretion.
- 29 April 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (19) , 15985-16006
Faster Amylin Aggregation on Fibrillar Collagen I Hastens Diabetic Progression through β-Cell Death and Loss of Function
Amyloid deposition of the neuroendocrine peptide amylin in islet tissues is a hallmark of type 2 diabetes (T2DM), leading to β-cell toxicity through nutrient deprivation, membrane rupture, and apoptosis. Though accumulation of toxic amylin aggregates in islet matrices is well documented, the role of the islet extracellular matrix in mediating amylin aggregation and its pathological consequences remains elusive. Here, we address this question by probing amylin interaction with collagen I (Col)─whose expression in the islet tissue increases during diabetes progression. By combining multiple biophysical techniques, we show that hydrophobic, hydrophilic, and cation-π interactions regulate amylin binding to Col, with fibrillar Col driving faster amylin aggregation. Amylin-entangled Col matrices containing high amounts of amylin induce death and loss of function in INS1E β-cells. Together, our results illustrate how amylin incorporation in islet matrices through amylin-Col interactions drives T2DM progression by impacting β-cell viability and insulin secretion.
- Open Access
PLGA–Soya Lecithin Based Hybrid Nanocomposite for Targeted Topical Delivery of Resveratrol in Psoriasis Management
Psoriasis is a recurring autoimmune-driven inflammatory skin disorder characterised by red, scaly, dry skin patches, keratinocyte hyperproliferation and infiltration of inflammatory cells, impacting millions globally. Patients with psoriasis often require repeated treatments with corticosteroids, which are often associated with significant side effects and comorbidities. Therefore, there is a growing need for advanced nanomedicine-based therapeutic approaches. Resveratrol (RSV), a plant-derived polyphenol, has shown promising anti-inflammatory and antioxidant properties for the treatment and management of psoriasis. However, its therapeutic potential is limited due to its poor solubility, low stability, and reduced skin penetration. To overcome these challenges, we have developed dual-carrier conjugated nanoparticles (RSVNPL) composed of soya lecithin and poly(lactic-co-glycolic acid) (PLGA). To further enhance its ease of application and prolong skin residence time, RSVNPL was incorporated into a carbomer 974P-based hydrogel system, forming RSVNPGel. Our formulation demonstrated improved physicochemical properties, including enhanced spreadability, superior skin adhesiveness and stability. Ex vivo skin permeation studies confirmed a significantly higher accumulation of RSV in the epidermis and dermis compared to free drugs. In vivo, efficacy was investigated using imiquimod (IMQ)-induced psoriatic mouse model, where RSVNPGel treatment led to a notable reduction in epidermal thickness, inflammatory cell infiltration, and key histopathological features associated with psoriasis. Additionally, serum biochemical analysis and organ histology established the biocompatibility and safety of the formulation. Overall, RSVNPGel presents a promising nanocarrier-based strategy for the effective topical management of psoriasis, enhancing RSV delivery and therapeutic efficacy while minimizing systemic exposure. Research Highlights: Hybrid nanoparticles composite of soya lecithin and PLGA were developed for RSV delivery. The formulation enhanced skin penetration, retention and created a better skin adhesive profile in psoriatic lesions. Significant anti-psoriatic effects were achieved in a preclinical model. The system showed excellent safety and biocompatibility. Graphical
Open AccessPLGA–Soya Lecithin Based Hybrid Nanocomposite for Targeted Topical Delivery of Resveratrol in Psoriasis Management
Psoriasis is a recurring autoimmune-driven inflammatory skin disorder characterised by red, scaly, dry skin patches, keratinocyte hyperproliferation and infiltration of inflammatory cells, impacting millions globally. Patients with psoriasis often require repeated treatments with corticosteroids, which are often associated with significant side effects and comorbidities. Therefore, there is a growing need for advanced nanomedicine-based therapeutic approaches. Resveratrol (RSV), a plant-derived polyphenol, has shown promising anti-inflammatory and antioxidant properties for the treatment and management of psoriasis. However, its therapeutic potential is limited due to its poor solubility, low stability, and reduced skin penetration. To overcome these challenges, we have developed dual-carrier conjugated nanoparticles (RSVNPL) composed of soya lecithin and poly(lactic-co-glycolic acid) (PLGA). To further enhance its ease of application and prolong skin residence time, RSVNPL was incorporated into a carbomer 974P-based hydrogel system, forming RSVNPGel. Our formulation demonstrated improved physicochemical properties, including enhanced spreadability, superior skin adhesiveness and stability. Ex vivo skin permeation studies confirmed a significantly higher accumulation of RSV in the epidermis and dermis compared to free drugs. In vivo, efficacy was investigated using imiquimod (IMQ)-induced psoriatic mouse model, where RSVNPGel treatment led to a notable reduction in epidermal thickness, inflammatory cell infiltration, and key histopathological features associated with psoriasis. Additionally, serum biochemical analysis and organ histology established the biocompatibility and safety of the formulation. Overall, RSVNPGel presents a promising nanocarrier-based strategy for the effective topical management of psoriasis, enhancing RSV delivery and therapeutic efficacy while minimizing systemic exposure. Research Highlights: Hybrid nanoparticles composite of soya lecithin and PLGA were developed for RSV delivery. The formulation enhanced skin penetration, retention and created a better skin adhesive profile in psoriatic lesions. Significant anti-psoriatic effects were achieved in a preclinical model. The system showed excellent safety and biocompatibility. Graphical
- 21 January 2025
- Published by Wiley in Journal of Cellular Physiology
- Vol. 240 (1) , e70001
CD44/Integrin β1 Association Drives Fast Motility on Hyaluronic Acid Substrates
In addition to proteins such as collagen (Col) and fibronectin, the extracellular matrix (ECM) is enriched with bulky proteoglycan molecules such as hyaluronic acid (HA). However, how ECM proteins and proteoglycans collectively regulate cellular processes has not been adequately explored. Here, we address this question by studying cytoskeletal and focal adhesion organization and dynamics on cells cultured on polyacrylamide hydrogels functionalized with Col, HA and a combination of Col and HA (Col/HA). We show that fastest migration on HA substrates is attributed to the presence of smaller and weaker focal adhesions. Integrin 1 co‐localization and its association with CD44—which is the receptor for HA, and insensitivity of cell spreading to RGD on HA substrates suggests that focal adhesions on HA substrates are formed via integrin association with HA bound CD44. Consistent with this, adhesion formation and cell motility were inhibited when CD44 was knocked out. Collectively, our results suggest that association of integrin 1 with CD44 drives fast motility on HA substrates.
- 21 January 2025
- Published by Wiley in Journal of Cellular Physiology
- Vol. 240 (1) , e70001
CD44/Integrin β1 Association Drives Fast Motility on Hyaluronic Acid Substrates
In addition to proteins such as collagen (Col) and fibronectin, the extracellular matrix (ECM) is enriched with bulky proteoglycan molecules such as hyaluronic acid (HA). However, how ECM proteins and proteoglycans collectively regulate cellular processes has not been adequately explored. Here, we address this question by studying cytoskeletal and focal adhesion organization and dynamics on cells cultured on polyacrylamide hydrogels functionalized with Col, HA and a combination of Col and HA (Col/HA). We show that fastest migration on HA substrates is attributed to the presence of smaller and weaker focal adhesions. Integrin 1 co‐localization and its association with CD44—which is the receptor for HA, and insensitivity of cell spreading to RGD on HA substrates suggests that focal adhesions on HA substrates are formed via integrin association with HA bound CD44. Consistent with this, adhesion formation and cell motility were inhibited when CD44 was knocked out. Collectively, our results suggest that association of integrin 1 with CD44 drives fast motility on HA substrates.
- 22 October 2024
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 7 (11) , 3592-3606
Eugenol-Loaded Lipid Nanoparticles-Derived Hydrogels Ameliorate Psoriasis-like Skin Lesions by Lowering Oxidative Stress and Modulating Inflammation
Psoriasis is a chronic T-cell-mediated autoimmune skin disorder characterized by excessive epidermal thickening, overproliferation of keratinocyte, disruption of epidermal cell differentiation, and increased blood vessel growth in the dermal layer. Despite the common use of corticosteroids in psoriasis treatment, their limited efficacy and numerous side effects pose significant challenges. This research introduces a promising alternative approach by encapsulating eugenol (EU) in soya phosphatidylcholine (SPC) nanoparticles (EUNPs) which showed spherical shape nanoparticles with a hydrodynamic size of approximately 200 nm, polydispersity index 0.23, encapsulation efficiency of 85% having good colloidal stability indicated by ζ-potential of -27 mV. Later on, these EUNPs were formulated into a topical hydrogel system by using Carbopol 974P (EUNPGel), which exhibited superior drug loading, enhanced release kinetics for 48 h, long-term stability, and the ability to scavenge reactive oxygen species (ROS). Furthermore, EUNPs inhibited keratinocyte proliferation, induced apoptosis, and augmented the uptake of IL-6-mediated inflammation in human keratinocyte cells. Application of EUNPs-loaded gels (EUNPGel) to imiquimod-induced psoriatic lesions demonstrated effective dermal penetration, suppressed keratinocyte hyperplasia and restored epidermal growth. This led to a remarkable reduction in the Psoriasis Area and Severity Index (PASI) score from 3.75 to 0.5 within 5 days. This novel approach enhances ROS scavenging capacity, improves cellular uptake, facilitates skin penetration and retention, reduces the activity of hyperactive immune cells, and suggests potential applications for treating other immune-related disorders such as acne and atopic dermatitis.
- 22 October 2024
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 7 (11) , 3592-3606
Eugenol-Loaded Lipid Nanoparticles-Derived Hydrogels Ameliorate Psoriasis-like Skin Lesions by Lowering Oxidative Stress and Modulating Inflammation
Psoriasis is a chronic T-cell-mediated autoimmune skin disorder characterized by excessive epidermal thickening, overproliferation of keratinocyte, disruption of epidermal cell differentiation, and increased blood vessel growth in the dermal layer. Despite the common use of corticosteroids in psoriasis treatment, their limited efficacy and numerous side effects pose significant challenges. This research introduces a promising alternative approach by encapsulating eugenol (EU) in soya phosphatidylcholine (SPC) nanoparticles (EUNPs) which showed spherical shape nanoparticles with a hydrodynamic size of approximately 200 nm, polydispersity index 0.23, encapsulation efficiency of 85% having good colloidal stability indicated by ζ-potential of -27 mV. Later on, these EUNPs were formulated into a topical hydrogel system by using Carbopol 974P (EUNPGel), which exhibited superior drug loading, enhanced release kinetics for 48 h, long-term stability, and the ability to scavenge reactive oxygen species (ROS). Furthermore, EUNPs inhibited keratinocyte proliferation, induced apoptosis, and augmented the uptake of IL-6-mediated inflammation in human keratinocyte cells. Application of EUNPs-loaded gels (EUNPGel) to imiquimod-induced psoriatic lesions demonstrated effective dermal penetration, suppressed keratinocyte hyperplasia and restored epidermal growth. This led to a remarkable reduction in the Psoriasis Area and Severity Index (PASI) score from 3.75 to 0.5 within 5 days. This novel approach enhances ROS scavenging capacity, improves cellular uptake, facilitates skin penetration and retention, reduces the activity of hyperactive immune cells, and suggests potential applications for treating other immune-related disorders such as acne and atopic dermatitis.